Hofseth BioCare ASA (HOFBF)
Hofseth BioCare ASA operates in the Packaged Foods industry of the Consumer Defensive sector, headquartered in Ålesund, MR, NO. The stock last traded at $0.12, up 0.00% on the session, giving a market capitalisation of $48.6M. On trailing twelve-month figures it carries a trailing P/E of -3.50, a net margin of -45.7%. Its beta of 0.26 implies it has historically moved less than the broad market.
Hofseth BioCare ASA, an international firm based in Norway, specializes in developing and supplying premium biomarine ingredients for both human and animal health. The company's product portfolio features various specialized offerings, including Brilliant salmon oil and OmeGo salmon oil, which promotes healthy cholesterol levels and supports cardiovascular well-being. ProGo, a salmon protein hydrolysate, serves as a rapidly assimilated protein supplement. For skeletal and joint health, Hofseth offers CalGo, a marine calcium powder. CollaGo, a collagen peptide powder, is designed to improve the appearance of hair, skin, and nails. Additionally, PetGo provides a non-soluble protein formulation. Distribution of these products is managed through a multi-channel approach, utilizing a network of distributors, agents, and its dedicated internal sales team. Hofseth BioCare also holds a significant research collaboration with Stanford University School of Medicine, focusing on pre-clinical and clinical studies related to conditions such as necrotizing enterocolitis and irritable bowel syndrome. Established in 2000, the company's main operations are based in Ålesund, Norway.
Hofseth BioCare ASA is most often compared with the following Consumer Defensive names: